We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Australia Leads Effort To Improve Diagnosis of Genetic Disorders

By LabMedica International staff writers
Posted on 17 Nov 2008
Australian scientists are leading a global initiative to improve the diagnosis of genetic disorders and reduce errors in the reporting of genetic variations. More...


Over 60% of people worldwide will be affected by a genetic change at some point in their lives that can result in a range of diseases such as cystic fibrosis, epilepsy, and cancer.

The Human Genome Project completed in early 2000, succeeded mapping the human genome. However, of the 20,000 human genes mapped, only 3,000 have any information available on their variations.

The Australian-led global project, called the Human Variome Project, is being conducted by University of Melbourne (Australia) investigators and colleagues within the Florey Neuroscience Institutes (Melbourne, Australia), the department of medicine at the Royal Melbourne Hospital (Melbourne, Australia), and the Epilepsy Research Center (Melbourne, Australia), together with other scientists from around the globe.

The global initiative was published in the November 2006 issue of the journal Science. Prof. Richard Cotton, lead author of the study, convener of the Human Variome Project, and honorary researcher at the University of Melbourne said, "There is a staggering error rate of up to 40% [in] some reporting of genetic variations. This means clinicians and specialists cannot solely rely on the research literature to inform the life and death decisions of diagnosis and prognosis of genetic disorders.”

The Human Variome Project will produce standards for the storage, transmission, and use of genetic variation information, which for many will reduce the enormously time-consuming task of seeking data to assist in providing patients with information.

A range of pilot projects are being organized around the world that will examine how to systematically collect genetic, clinical, and biochemical information in either a country- specific or gene-specific manner. Countries already planning to participate in these projects include Australia, China, Japan, and Kuwait.

The project has the support of World Health Organization (WHO; Geneva, Switzerland), the United Nations Scientific and Cultural Organization (UNESCO), and the Organization for Economic Cooperation and Development (OECD) countries.

Related Links:
University of Melbourne
Florey Neuroscience Institutes
Department of Medicine at the Royal Melbourne Hospital
Epilepsy Research Center
World Health Organization
United Nations Scientific and Cultural Organization
Organization for Economic Cooperation and Development


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Platelet Function Analyzer
PL-12
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: (a) CTC separation using contraction-expansion inertial microfluidics. (b) CTC detection using the YOLOv8 deep learning model. (Image Credit: Junyi Ouyang, Haiqin Li)

Label-Free Platform Combines Microfluidics and AI for Circulating Tumor Cell Analysis

Liquid biopsy relies on detecting rare tumor-derived material in blood, but circulating tumor cells (CTCs) are especially difficult to capture because they are vastly outnumbered by normal blood cells.... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.